197 related articles for article (PubMed ID: 38107492)
1. Development of a prognostic nomogram for lymph node positive HR
Cheng X; Jiang J; Liang X; Zheng X
Gland Surg; 2023 Nov; 12(11):1541-1553. PubMed ID: 38107492
[TBL] [Abstract][Full Text] [Related]
2. An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes.
Ren F; Yang C; Liu J; Feng K; Shang Q; Kang X; Zhang R; Li L; Zhao S; Wang X; Wang X
Transl Cancer Res; 2024 Feb; 13(2):935-951. PubMed ID: 38482409
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for hormone receptor-positive breast cancer with liver metastasis and establishment of novel nomograms for prediction: a SEER-based study.
Xu Z; Chen Y; Dai Y; Chen Y; Ding J
Transl Cancer Res; 2023 Dec; 12(12):3672-3692. PubMed ID: 38193003
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for early HER2-positive and lymph node-negative breast cancer.
Shi Q; Wang J; Ai X; Xuhong J; Ma D; Zhang Y; Qi X; Jiang J
Gland Surg; 2021 Jul; 10(7):2255-2265. PubMed ID: 34422596
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.
Wang H; Xia GF; Zhang ZR; Luo X; Zhu JY; Wang HK
Am J Cancer Res; 2023; 13(11):5065-5081. PubMed ID: 38058820
[TBL] [Abstract][Full Text] [Related]
6. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
[TBL] [Abstract][Full Text] [Related]
7. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
Teng L; Du J; Yan S; Xu P; Liu J; Zhao X; Tao W
Breast Cancer; 2024 May; ():. PubMed ID: 38802681
[TBL] [Abstract][Full Text] [Related]
8. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort.
Dong X; Wang K; Yang H; Cheng R; Li Y; Hou Y; Chang J; Yuan L
Front Endocrinol (Lausanne); 2023; 14():1266318. PubMed ID: 37955009
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.
Li J; Cui T; Huang Z; Mu Y; Yao Y; Xu W; Chen K; Liu H; Wang W; Chen X
Front Oncol; 2023; 13():1062142. PubMed ID: 37007147
[TBL] [Abstract][Full Text] [Related]
10. Construction and validation of nomogram for the cancer-specific mortality for HER2-positive breast cancer patients.
Wu N
Medicine (Baltimore); 2024 Mar; 103(11):e37330. PubMed ID: 38489717
[TBL] [Abstract][Full Text] [Related]
11. Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.
Guan D; Jie Q; Wu Y; Xu Y; Hong W; Meng X
World J Surg Oncol; 2022 Sep; 20(1):326. PubMed ID: 36175898
[TBL] [Abstract][Full Text] [Related]
12. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
13. Nomogram models for stratified prediction of axillary lymph node metastasis in breast cancer patients (cN0).
Gao X; Luo W; He L; Yang L
Front Endocrinol (Lausanne); 2022; 13():967062. PubMed ID: 36111297
[TBL] [Abstract][Full Text] [Related]
14. Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study.
Chu J; Yang D; Wang L; Xia J
Ann Transl Med; 2020 Apr; 8(8):544. PubMed ID: 32411767
[TBL] [Abstract][Full Text] [Related]
15. Nomograms predict survival in elderly women with triple-negative breast cancer: A SEER population-based study.
Feng R; Huang W; Liu B; Li D; Zhao J; Yu Y; Cao X; Wang X
Technol Health Care; 2024 Jan; ():. PubMed ID: 38306071
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort.
Li Y; Liu J; Xu Z; Shang J; Wu S; Zhang M; Liu Y
Front Oncol; 2023; 13():1231302. PubMed ID: 37954073
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database.
Zhang S; Xiao X; Qin X; Xia H
Transl Cancer Res; 2023 Oct; 12(10):2742-2753. PubMed ID: 37969392
[TBL] [Abstract][Full Text] [Related]
18. Candidates of Genomic Tests in HR+/HER2- Breast Cancer Patients With 1-2 Positive Sentinel Lymph Node Without Axillary Lymph Node Dissection: Analysis From Multicentric Cohorts.
Bi Z; Chen JJ; Liu PC; Chen P; Wang WL; Liu YB; Wang CJ; Qiu PF; Lv Q; Wu J; Wang YS
Front Oncol; 2021; 11():722325. PubMed ID: 34422668
[TBL] [Abstract][Full Text] [Related]
19. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
[No Abstract] [Full Text] [Related]
20. Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database.
Zhan X; Jiang M; Deng W; Liu X; Chen L; Fu B
Front Oncol; 2022; 12():789028. PubMed ID: 35186736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
